Vaccines

PPD Selected as a Preferred Provider to Global Health Product Development Partnership Consortium

Published in Vaccine Weekly, April 13th, 2011

2011 APR 13 -- PPD, Inc. (Nasdaq: PPDI) announced it has been chosen as a preferred provider to a consortium of 14 global health Product Development Partners (PDPs) to bring safe, new medicines to the developing world. PPD will have the opportunity to work closely with the PDPs to deliver global clinical research and development services that advance global health in the world's poorest countries.

PPD is expected to provide a broad range of discovery, clinical development and post-approval services for drug and vaccine development. The company will strengthen local research capacities through program and site management, trial monitoring, specialized...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2011-04-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry